BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29157380)

  • 1. Staging of Non-Small-Cell Lung Cancer.
    Akhurst T
    PET Clin; 2018 Jan; 13(1):1-10. PubMed ID: 29157380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer.
    Kandathil A; Kay FU; Butt YM; Wachsmann JW; Subramaniam RM
    Radiographics; 2018; 38(7):2134-2149. PubMed ID: 30422775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilemmas in Lung Cancer Staging.
    Vlahos I
    Radiol Clin North Am; 2018 May; 56(3):419-435. PubMed ID: 29622077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging in Lung Cancer Staging.
    Strange CD; Strange TA; Erasmus LT; Patel S; Ahuja J; Shroff GS; Agrawal R; Truong MT
    Clin Chest Med; 2024 Jun; 45(2):295-305. PubMed ID: 38816089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
    Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
    Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment.
    Nakajima T; Yasufuku K; Nakajima M; Baba M; Yoshikawa K; Kamada T; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I
    J Thorac Oncol; 2010 May; 5(5):606-11. PubMed ID: 20354458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.
    Harders SW; Madsen HH; Hjorthaug K; Arveschoug AK; Rasmussen TR; Meldgaard P; Hoejbjerg JA; Pilegaard HK; Hager H; Rehling M; Rasmussen F
    Cancer Imaging; 2014 Jun; 14(1):23. PubMed ID: 25608616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Computed tomography imaging of non-small cell lung cancer].
    Chassagnon G; Bennani S; Revel MP
    Cancer Radiother; 2016 Oct; 20(6-7):694-8. PubMed ID: 27614518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of Lung Cancer Staging.
    Archer JM; Truong MT; Shroff GS; Godoy MCB; Marom EM
    Semin Respir Crit Care Med; 2022 Dec; 43(6):862-873. PubMed ID: 35815631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.
    Abramyuk A; Appold S; Zöphel K; Hietschold V; Baumann M; Abolmaali N
    Lung Cancer; 2012 Nov; 78(2):148-52. PubMed ID: 22922126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET in lung cancer staging.
    Coleman RE
    Q J Nucl Med; 2001 Sep; 45(3):231-4. PubMed ID: 11788815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
    Antoch G; Stattaus J; Nemat AT; Marnitz S; Beyer T; Kuehl H; Bockisch A; Debatin JF; Freudenberg LS
    Radiology; 2003 Nov; 229(2):526-33. PubMed ID: 14512512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer].
    Weber WA; Dietlein M; Hellwig D; Kirsch CM; Schicha H; Schwaiger M
    Nuklearmedizin; 2003 Aug; 42(4):135-44. PubMed ID: 12937692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography/computed tomography (PET/CT) and CT for N staging of non-small cell lung cancer.
    Vegar Zubović S; Kristić S; Hadžihasanović B
    Med Glas (Zenica); 2017 Aug; 14(2):199-203. PubMed ID: 28698537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET and PET-CT of lung cancer.
    Steinert HC
    Methods Mol Biol; 2011; 727():33-51. PubMed ID: 21331927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endosonography for lung cancer staging: predictors for false-negative outcomes.
    Talebian Yazdi M; Egberts J; Schinkelshoek MS; Wolterbeek R; Nabers J; Venmans BJ; Tournoy KG; Annema JT
    Lung Cancer; 2015 Dec; 90(3):451-6. PubMed ID: 26477967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic tumor burden quantified on [
    Lapa P; Oliveiros B; Marques M; Isidoro J; Alves FC; Costa JMN; Costa G; de Lima JP
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2169-2178. PubMed ID: 28785842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.